National Guideline Clearinghouse | Rituximab in chronic lymphocytic leukemia.

Guideline Title
Cancer Care Ontario Web site [CCO]
Rituximab in chronic lymphocytic leukemia.

Bibliographic Source(s)
Cheung M, Tey R, Haynes A. Rituximab in chronic lymphocytic leukemia. Toronto (ON): Cancer Care Ontario (CCO); 2009 Nov 18. 14 p. (CED-CCO special advice report; no. 15). [19 references]

Guideline Status
This is the current release of the guideline.

The SPECIAL ADVICE report over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site [CCO]
for details on any new evidence that has emerged and implications to the guidelines.

full-text:
National Guideline Clearinghouse | Rituximab in chronic lymphocytic leukemia.